Kerollos Nashat Wanis1, Michael Ott2, Julie Ann M Van Koughnett2, Patrick Colquhoun2, Muriel Brackstone2. 1. Department of Surgery, Western University, London Health Sciences Centre, Rm. C8-114, London, Ontario, N6A 5A5, Canada. knwanis@g.harvard.edu. 2. Department of Surgery, Western University, London Health Sciences Centre, Rm. C8-114, London, Ontario, N6A 5A5, Canada.
Abstract
PURPOSE: The relationship between emergency colon cancer resection and long-term oncological outcomes is not well understood. Our objective was to characterize the impact of emergency resection for colon cancer on disease-free and overall patient survival. METHODS: Data on patients undergoing resection for colon cancer from 2006 to 2015 were collected from a prospectively maintained clinical and administrative database. The median follow-up time was 4.4 years. Cox proportional hazards models were used to estimate the hazard ratios for recurrence and death for patients treated with surgery for an emergent presentation. Differences in initiation of, and timeliness of, adjuvant chemotherapy between emergently and electively treated patients were also examined. RESULTS: Of the 1180 patients who underwent resection for stages I, II, or III colon cancer, 158 (13%) had emergent surgery. After adjustment for patient, tumor, and treatment characteristics, the HR for recurrence was 1.64 (95% CI 1.12-2.40) and for death was 1.47 (95% CI 1.10-1.97). After adjustment for tumor characteristics, patients who underwent emergency resection were similarly likely to receive adjuvant chemotherapy (OR 1.1; 95% CI 0.70-1.76). The time from surgery to initiation of adjuvant chemotherapy was also similar between the groups. CONCLUSIONS: Emergency surgery for localized or regional colon cancer is associated with a greater risk of recurrence and death. This association does not appear to be due to differences in adjuvant treatment. A focus on screening and colon cancer awareness in order to reduce emergency presentations is warranted.
PURPOSE: The relationship between emergency colon cancer resection and long-term oncological outcomes is not well understood. Our objective was to characterize the impact of emergency resection for colon cancer on disease-free and overall patient survival. METHODS: Data on patients undergoing resection for colon cancer from 2006 to 2015 were collected from a prospectively maintained clinical and administrative database. The median follow-up time was 4.4 years. Cox proportional hazards models were used to estimate the hazard ratios for recurrence and death for patients treated with surgery for an emergent presentation. Differences in initiation of, and timeliness of, adjuvant chemotherapy between emergently and electively treated patients were also examined. RESULTS: Of the 1180 patients who underwent resection for stages I, II, or III colon cancer, 158 (13%) had emergent surgery. After adjustment for patient, tumor, and treatment characteristics, the HR for recurrence was 1.64 (95% CI 1.12-2.40) and for death was 1.47 (95% CI 1.10-1.97). After adjustment for tumor characteristics, patients who underwent emergency resection were similarly likely to receive adjuvant chemotherapy (OR 1.1; 95% CI 0.70-1.76). The time from surgery to initiation of adjuvant chemotherapy was also similar between the groups. CONCLUSIONS: Emergency surgery for localized or regional colon cancer is associated with a greater risk of recurrence and death. This association does not appear to be due to differences in adjuvant treatment. A focus on screening and colon cancer awareness in order to reduce emergency presentations is warranted.
Authors: Zhaomin Xu; Adan Z Becerra; Christopher T Aquina; Bradley J Hensley; Carla F Justiniano; Courtney Boodry; Alex A Swanger; Reza Arsalanizadeh; Katia Noyes; John R Monson; Fergal J Fleming Journal: J Gastrointest Surg Date: 2017-01-12 Impact factor: 3.452
Authors: Lane Smothers; Linda Hynan; Jason Fleming; Richard Turnage; Clifford Simmang; Thomas Anthony Journal: Dis Colon Rectum Date: 2003-01 Impact factor: 4.585
Authors: Benjamin Weixler; Rene Warschkow; Michaela Ramser; Raoul Droeser; Urs von Holzen; Daniel Oertli; Christoph Kettelhack Journal: BMC Cancer Date: 2016-03-11 Impact factor: 4.430
Authors: Simone Sibio; A Di Giorgio; S D'Ugo; G Palmieri; L Cinelli; V Formica; B Sensi; G Bagaglini; S Di Carlo; V Bellato; G S Sica Journal: Langenbecks Arch Surg Date: 2019-11-23 Impact factor: 3.445
Authors: Jeske R E Boeding; Winesh Ramphal; Arjen M Rijken; Rogier M P H Crolla; Cornelis Verhoef; Paul D Gobardhan; Jennifer M J Schreinemakers Journal: Ann Surg Oncol Date: 2020-10-16 Impact factor: 5.344
Authors: L Siragusa; B Sensi; D Vinci; M Franceschilli; C Pathirannehalage Don; G Bagaglini; V Bellato; M Campanelli; G S Sica Journal: Discov Oncol Date: 2021-04-12